EMA Recommends Extension of Indications for Dostarlimab By Ogkologos - January 23, 2025 590 0 Facebook Twitter Google+ Pinterest WhatsApp Change concerns the first-line treatment of patients with endometrial cancer Source RELATED ARTICLESMORE FROM AUTHOR Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours Rare Disease Day 2026: Advancing equity for people living with rare cancers in Europe EMA Recommends Extension of Therapeutic Indications for Ponatinib MOST POPULAR Selpercatinib Approved for Thyroid and Lung Cancers with RET Gene Alterations June 15, 2020 Adjuvant Abemaciclib Combined with Endocrine Therapy Improves IDFS in HR-Positive, HER2−Negative,... October 19, 2021 This Common Antibiotic May Help Support Immune System in Cancer Patients... December 12, 2019 German Shepherds Detect Fast-Growing Form Of Breast Cancer And Save Their... February 18, 2020 Load more HOT NEWS Latest episode of our podcast for cancer researchers Breast Cancer Patient Who Continued Teaching Throughout Her Treatment Wins Teacher... After Saving Thousands of Dogs, Tragedy Strikes Famed Rescue Family Coronavirus reports – Part 6 “The kids being home all the...
